Clinical Trial Detail

NCT ID NCT01854034
Title Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

lung non-small cell carcinoma

Therapies

Luminespib

Age Groups: adult

No variant requirements are available.